Treatment of recalcitrant warts with intralesional measles, mumps, and rubella vaccine: a promising approach

E-ISSN： 1365-4632|54|6|667-671

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.54, Iss.6, 2015-06, pp. : 667-671

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

JOURNAL OF PAEDIATRICS AND CHILD HEALTH, Vol. 51, Iss. 8, 2015-08 ,pp. : 838-838

John Wiley & Sons Inc

Access to resources Recommend Favorite

Suspected measles–mumps–rubella vaccine-related encephalitis: Two cases

By Shuper Avinoam

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 1, 2011-01 ,pp. : 75-78

Informa Healthcare

Access to resources Recommend Favorite

Immunogenicity and Reactogenicity of a New Measles, Mumps and Rubella Vaccine When Administered as a Second Dose at 12 y of Age

By Gothefors Leif Bergström Erik Bäckman Margareta

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 7, 2001-07 ,pp. : 545-549

Informa Healthcare

Access to resources Recommend Favorite

Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany

Epidemiology and Infection, Vol. 145, Iss. 2, 2017-01 ,pp. : 236-244

Cambridge University Press

Access to resources Recommend Favorite

Immunogenicity and Reactogenicity of a Single Dose of Live Attenuated Varicella Vaccine and a Booster Dose of Measles-Mumps-Rubella Vaccine Given Concomitantly at 12 years of Age

By Parment Per Arne Svahn Anita Rudén Ulla Bråkenhielm Görel Storsaeter Jann Åkesson Lena Linde Annika

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 10, 2003-10 ,pp. : 736-742

Informa Healthcare

Access to resources Recommend Favorite